The rising prevalence in GLP-1 agonists for metabolic health has led to a question about application forms : skin-applied devices versus tablets . Traditionally , GLP-1 drugs were only available in oral https://tayanvog423082.bloggosite.com/48799089/glp-1-transdermal-delivery-systems-vs-oral-medications-is-best-for-the-patient